Adial Pharmaceuticals Reaches Full Enrollment Target for ONWARD™ Phase 3 Trial of AD04 for the ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Latvia ,Estonia ,United States ,Croatia ,Sweden ,Finland ,Helsinki ,Eteläuomen Läi ,Bulgaria ,Poland ,William Stilley ,David Waldman Natalya Rudman ,Exchange Commission ,Adial Pharmaceuticals Inc ,University Of Helsinki ,Crescendo Communications ,Adial Pharmaceuticals ,Nasdaq ,Alcohol Use Disorder ,Chief Executive Officer ,Opioid Use Disorder ,Pivotal Phase ,Eastern Europe ,Emeritus Professor ,Addiction Medicine ,Annual Report ,Quarterly Reports ,Natalya Rudman ,Business ,Science ,Health ,Globe Newswire ,